These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 28803520)

  • 1. Probable Rivaroxaban-Induced Full Body Rash: A Case Report.
    Sasson E; James M; Russell M; Todorov D; Cohen H
    J Pharm Pract; 2018 Oct; 31(5):503-506. PubMed ID: 28803520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rivaroxaban-Induced Acute Interstitial Nephritis: A Case Report.
    Zafar F; Iqbal AM; Mubarik A; Rojas M; Muddassir S
    Am J Case Rep; 2019 Nov; 20():1719-1722. PubMed ID: 31748498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivaroxaban induced petechial purpuric rash over chest at precordial chest leads of ECG.
    Inamadar A
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35732360
    [No Abstract]   [Full Text] [Related]  

  • 4. Apixaban (Eliquis)-Induced Rash: A Case Report.
    Nadella H; Vilar N; Nochimson R
    Cureus; 2023 Dec; 15(12):e50273. PubMed ID: 38196431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amoxicillin Induced Fever, Rash, and Catatonia - A Case Study.
    Yadav CK; Ranka R; Panda PK; Shah BP; Mishra MK; Krishnan V
    Curr Drug Saf; 2024; 19(2):282-285. PubMed ID: 36892033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Severe hepatopathy following rivaroxaban administration in a dog.
    Mosichuk AP; Wimbish C; Poplawski K; Birkenheuer A; Harrell K; Pierce KV
    Front Vet Sci; 2024; 11():1364677. PubMed ID: 38638638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran - A Case Report.
    Gumbis G; Česnavičiūtė I; Didžiokaitė G; Gegeckienė D; Kvedarienė V
    J Asthma Allergy; 2023; 16():1133-1138. PubMed ID: 37841493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probable rivaroxaban-induced erythema multiforme in children: A case report.
    Cao Z; Fu Z; Liu Y; Liu T; Zhan M; Liu X; Cheng X
    Saudi Pharm J; 2023 Nov; 31(11):101801. PubMed ID: 37829191
    [No Abstract]   [Full Text] [Related]  

  • 9. Atomoxetine-Associated Maculopapular Rash: A Case Report.
    Ince N; Sari SA
    J Clin Psychopharmacol; 2023 Nov-Dec 01; 43(6):539-541. PubMed ID: 37930210
    [No Abstract]   [Full Text] [Related]  

  • 10. Rivaroxaban for a Patient with Class III Obesity: Case Report with Literature Review.
    Bates D; Edwards J; Shrum J; Chan C; Manga S; MacKay E
    Can J Hosp Pharm; 2018; 71(1):36-43. PubMed ID: 29531396
    [No Abstract]   [Full Text] [Related]  

  • 11. A young woman with a full-body rash.
    Sadr PZ; Pishbin E; Khodashahi R
    J Am Coll Emerg Physicians Open; 2020 Oct; 1(5):1145-1146. PubMed ID: 33145582
    [No Abstract]   [Full Text] [Related]  

  • 12. Case 1: Pneumonia with hypotension and a rash.
    Kanani R; Smith WG
    Paediatr Child Health; 2004 Sep; 9(7):473-5. PubMed ID: 19657413
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric patient with a rash.
    Hoffman C; Francis S
    J Am Coll Emerg Physicians Open; 2020 Aug; 1(4):650-651. PubMed ID: 33000086
    [No Abstract]   [Full Text] [Related]  

  • 14. Dialysis Patient With a Unique Rash.
    Cyriac A; Allen SL; Cyriac S; Jhaveri KD
    Kidney Med; 2024 Jul; 6(7):100838. PubMed ID: 38947774
    [No Abstract]   [Full Text] [Related]  

  • 15. A rash assessment.
    Maurer BT
    JAAPA; 2024 Apr; 37(4):50. PubMed ID: 38531035
    [No Abstract]   [Full Text] [Related]  

  • 16. Rash associated with rivaroxaban use.
    Rudd KM; Panneerselvam N; Patel A
    Am J Health Syst Pharm; 2018 Mar; 75(6):347-349. PubMed ID: 29348123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study.
    Kreutz R; Persson PB; Kubitza D; Thelen K; Heitmeier S; Schwers S; Becka M; Hemmrich M
    J Thromb Haemost; 2017 Oct; 15(10):2017-2028. PubMed ID: 28805299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation.
    Horinaka S; Sugawara R; Yonezawa Y; Ishimitsu T
    Br J Clin Pharmacol; 2018 Jan; 84(1):79-87. PubMed ID: 28888219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Direct-Acting Oral Anticoagulant Use in Patients With Cancer.
    Davis DO; Davis KA
    J Pharm Pract; 2018 Oct; 31(5):441-444. PubMed ID: 28803521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban-Induced Hypersensitivity Syndrome.
    Chiasson CO; Canneva A; Roy FO; Doré M
    Can J Hosp Pharm; 2017; 70(4):301-304. PubMed ID: 28894315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.